Photo of Sanford D. Bishop, Jr.
D United States House · District 2 · Georgia On the 2026 ballot

Rep. Sanford D. Bishop, Jr.

Compare
Total votes
2,837
all sessions
Attendance
99%
34 missed
Near the chamber average
With party
97%
of cast votes
Lower than 79% of chamber peers
Bipartisan score
2%
crosses aisle rarely
Higher than 78% of chamber peers
Sponsored
1,335
bills & resolutions
Near the chamber average
Committees
4
assignments
1,335 bills and resolutions

Sponsored bills

Total
1,335
Primary
27
Co-sponsor
1,308
This page
1,335
matching current filters
Co-sponsor HRES 878
In committee · Indiana House · Co-sponsor
Recognizing the seriousness of polycystic ovary syndrome (PCOS) and expressing support for the designation of the month of September 2022 as "PCOS Awareness Month".

This resolution expresses support for the goals and ideals of PCOS Awareness Month. Polycystic ovary syndrome (PCOS) is caused by a hormone imbalance. Symptoms can include infertility, weight gain, excess hair growth, and acne.

In committee Jan 20, 2022 1 co-sponsor
Co-sponsor HR 6377
In committee · Indiana House · Co-sponsor
Free At-Home Tests for All Act

Free At-Home Tests for All Act This bill requires the Department of Health and Human Services (HHS) to provide free antigen diagnostic tests for COVID-19 (i.e., rapid tests) to U.S. residents. The bill also automatically grants emergency use authorization for rapid tests approved by certain foreign regulators. Specifically, HHS must purchase a sufficient quantity of rapid tests to provide two tests per week at no cost to each resident for the 12 months following the bill's enactment. The President may use authorities available under the Defense Production Act of 1950 to obtain the tests. That act confers upon the President a broad set of authorities to influence domestic industry in order to provide essential materials and goods needed for the national defense. In addition, HHS must conduct outreach about the availability of free rapid tests to Medicare and Medicaid participants and make the tests available through those programs. The bill also automatically grants emergency use authorization during the public health emergency for rapid tests that are listed for emergency use by (1) the World Health Organization (WHO), or (2) a foreign regulator that is a stringent regulatory authority as defined by the WHO for purposes of medicine procurement. The Food and Drug Administration (FDA) may rescind authority for, or otherwise regulate, a rapid test that was automatically authorized. Additionally, the FDA must establish a permanent advisory committee focused on diagnostic and serological testing for public health needs.

In committee Jan 13, 2022 1 co-sponsor
Co-sponsor HR 6323
In committee · Indiana House · Co-sponsor
Survivor Benefits Fairness Act

Survivor Benefits Fairness Act This bill adjusts the effective date of a reduction or discontinuance of compensation, dependency and indemnity compensation, or pension payments to the last day of the month during which a marriage, remarriage, or death of a payee occurs.

In committee Jan 6, 2022 1 co-sponsor
Co-sponsor HR 6244
In committee · Indiana House · Co-sponsor
Max Cleland VA Medical Center Act

Max Cleland VA Medical Center Act This bill designates the Department of Veterans Affairs medical center in Atlanta, Georgia, as the Joseph Maxwell Cleland Atlanta Department of Veterans Affairs Medical Center or the Joseph Maxwell Cleland Atlanta VA Medical Center.

In committee Jan 6, 2022 1 co-sponsor
Co-sponsor HR 6117
In committee · Indiana House · Co-sponsor
PrEP Access and Coverage Act

PrEP Access and Coverage Act This bill requires private health insurance plans to cover prescription drugs that prevent HIV, including related screenings, diagnostic procedures, administrative fees, and clinical follow-ups, without any cost-sharing obligation for the plan holder. Further, insurance plans must not impose any preauthorization requirement for this coverage. These coverage requirements also apply to public health insurance programs, including Medicare, Medicaid, and the Children's Health Insurance Program. Additionally, the bill prohibits denying, limiting, or qualifying coverage or increasing premiums for disability insurance, long-term care insurance, or life insurance policies based on an individual taking medication for HIV prevention. The bill further requires the Department of Health and Human Services to award grants to states, or directly to eligible local organizations, to provide uninsured individuals and underinsured individuals access to prescription drugs and related services that prevent HIV. The Centers for Disease Control and Prevention also must develop a public awareness campaign that focuses efforts in communities with a high need for HIV prevention treatment.

In committee Jan 6, 2022 1 co-sponsor
Co-sponsor HR 6272
In committee · Indiana House · Co-sponsor
College Student Hunger Act of 2021

College Student Hunger Act of 20 21 This bill modifies the eligibility requirements for the Supplemental Nutrition Assistance Program (SNAP) to make additional students at institutions of higher education eligible for benefits.

In committee Jan 4, 2022 1 co-sponsor
Co-sponsor HR 6000
In committee · Indiana House · Co-sponsor
Cures 2.0 Act

Cures 2.0 Act This bill addresses pandemic preparedness and public health issues, caregiver and patient engagement, drug development, insurance coverage, and biomedical research. The Department of Health and Human Services (HHS) must undertake research and other activities concerning COVID-19 and develop a strategy for future pandemics and declared emergencies. Additionally, the bill specifies actions to combat antimicrobial resistance. HHS may award grants for caregiver training. The bill also addresses diversity in clinical trials, collecting patient experience data during clinical trials, and coverage for care related to participation in specified clinical trials. The bill modifies the timeframe and requires additional guidance relating to expedited approval of certain breakthrough drugs, devices, or products. It also establishes two intercenter institutes within the Food and Drug Administration (FDA) focused on particular diseases that meet specified criteria. The bill also addresses (1) coverage in Medicare, Medicaid, and the Children's Health Insurance Program for telehealth, genetic and genomic testing, and other services; (2) electronic prescribing standards for Medicare drug benefits; and (3) access to Medicare and Medicaid claims data by certain registries. Furthermore, the bill prohibits the use of geographic tracking or biometrics in Medicaid electronic visit verification systems. The bill establishes the Advanced Research Projects Agency for Health (ARPA-H) within the National Institutes of Health to accelerate biomedical research and innovation through grants, contracts, cash prizes, and other means. The FDA may work with ARPA-H to expedite the development of medical products through specified activities.

In committee Jan 4, 2022 1 co-sponsor
Showing 1,021 to 1,030 of 1,335 bills